
Verrica Pharmaceuticals Streamlines Operations to Enhance YCANTH Access
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced a strategic restructuring aimed at reducing costs and broadening the reach of YCANTH®, its treatment for molluscum contagiosum.
Verrica Pharmaceuticals Streamlines Operations to Enhance YCANTH Access Read More